Nanobiotix (LTS:0QAV) Total Assets: €67.76 Mil (As of Dec. 2025)

What is Nanobiotix Total Assets?

Nanobiotix LTS:0QAV +3.91% 28 Total Assets is €67.76 Mil as of Dec. 2025. GuruFocus rates LTS:0QAV with a GF Score™ of 28/100. The stock has 3 warning signs investors should review.

Nanobiotix's Total Assets for the quarter that ended in Dec. 2025 was €67.76 Mil.

During the past 12 months, Nanobiotix's average Total Assets Growth Rate was -15.10% per year. During the past 3 years, the average Total Assets Growth Rate was -6.50% per year. During the past 5 years, the average Total Assets Growth Rate was 0.10% per year. During the past 10 years, the average Total Assets Growth Rate was 7.30% per year.

During the past 13 years, Nanobiotix's highest 3-Year average Total Assets Growth Rate was 78.20%. The lowest was -6.50%. And the median was 17.25%.

Total Assets is connected with ROA %. Nanobiotix's annualized ROA % for the quarter that ended in Dec. 2025 was -65.80%. Total Assets is also linked to Revenue through Asset Turnover. Nanobiotix's Asset Turnover for the quarter that ended in Dec. 2025 was 0.08.

Nanobiotix (LTS:0QAV) Total Assets Explanation

Total Assets is connected with ROA %.

Nanobiotix's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %	=	Net Income (Q: Dec. 2025 )	/	( (Total Assets (Q: Jun. 2025 )	+	Total Assets (Q: Dec. 2025 ))	/ count )
	=	-37.156	/	( (45.174	+	67.76)	/ 2 )
	=	-37.156	/	56.467
	=	-65.80 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Nanobiotix's Asset Turnover for the quarter that ended in Dec. 2025 is

	Asset Turnover
=	Revenue (Q: Dec. 2025 )	/	( (Total Assets (Q: Jun. 2025 )	+	Total Assets (Q: Dec. 2025 ))	/ count )
=	4.715	/	( (45.174	+	67.76)	/ 2 )
=	4.715	/	56.467
=	0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Nanobiotix Total Assets Related Terms

Nanobiotix Total Assets Historical Data

* Premium members only.

The historical data trend for Nanobiotix's Total Assets can be seen below:

Nanobiotix Total Assets Chart

Nanobiotix Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Assets

Get a 7-Day Free Trial

101.77

59.77

93.90

67.42

67.76

Nanobiotix Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Total Assets	Get a 7-Day Free Trial															93.90	86.68	67.42	45.17	67.76

28GF Score

Nanobiotix SA LTS:0QAV

Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Nanobiotix Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Nanobiotix's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets	=	Total Equity (A: Dec. 2025 )	+	Total Liabilities (A: Dec. 2025 )
	=	-84.483	+	152.243
	=	67.76

Nanobiotix's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2025 )	+	Total Liabilities (Q: Dec. 2025 )
	=	-84.483	+	152.243
	=	67.76

Frequently Asked Questions Learn more about Total Assets →

What does a Total Assets of €67.76 Mil mean?

Nanobiotix (LTS:0QAV) has a Total Assets of €67.76 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Nanobiotix and its competitors.

Is Nanobiotix's Total Assets too high?

Nanobiotix's current Total Assets is €67.76 Mil. Overall, Nanobiotix has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.

How does Nanobiotix's Total Assets compare to VRTX and REGN?

Nanobiotix's Total Assets of €67.76 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Assets for a Biotechnology company?

A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Assets mean?

A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Nanobiotix and its competitors. Nanobiotix's current Total Assets is €67.76 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Nanobiotix stock overvalued right now?

Nanobiotix (LTS:0QAV) has a current Total Assets of €67.76 Mil. The current Total Assets is €67.76 Mil. Nanobiotix's overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Assets calculated?

Total Assets is calculated from a company's financial statements. For Nanobiotix (LTS:0QAV), the current Total Assets is €67.76 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nanobiotix Business Description

Industry Healthcare Biotechnology

Comparable Companies XPAR:MEDCL XPAR:DBV XPAR:IVA XPAR:GNFT XPAR:VLA XPAR:ALCLS XPAR:TNG XPAR:IPH XPAR:ALSEN XPAR:ALVIO VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges NBTX:USA NANO:France 5NR:Germany

Address 60 Rue de Wattignies, Paris, FRA, 75012

Website https://www.nanobiotix.com

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

28GF Score

Get the complete analysis for LTS:0QAV

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€34.88

Price

View LTS:0QAV Analysis

See Total Assets data for all stocks →